Lloyd F. Craver
Memorial Hospital of South Bend
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Lloyd F. Craver.
The American Journal of Medicine | 1961
Ruven Levitan; Henry D. Diamond; Lloyd F. Craver
Abstract The pertinent literature dealing with jaundice in Hodgkins disease is reviewed, and an analysis is made of a series of 116 cases of jaundiced patients with Hodgkins disease observed at the Memorial Center. The pertinent pathologic findings in fifty-seven patients who came to autopsy also are presented. Evaluation of the cause of jaundice in Hodgkins disease often is difficult. The chief cause of jaundice in our autopsy series was, in order of frequency, liver involvement with Hodgkins disease (70.2 per cent), no satisfactory pathologic or clinical explanation of jaundice (14 per cent), hemolytic anemia (5.2 per cent), extrahepatic bile duct obstruction due to tumor (3.5 per cent), hepatitis (3.5 per cent), choledocholithiasis (1.8 per cent), cirrhosis (1.8 per cent). The conventional liver function tests were not very helpful in establishing the cause of jaundice. Liver biopsy, whenever feasible and not contraindicated by the danger of hemorrhage, should be used more extensively in order to establish the cause of jaundice. Some therapeutic considerations in the jaundiced patient with Hodgkins disease are discussed.
Gut | 1961
Ruven Levitan; Henry D. Diamond; Lloyd F. Craver
This is a survey of the incidence, morphology, and significance of hepatic changes in Hodgkins disease
Annals of Internal Medicine | 1960
Saul A. Rosenberg; Henry D. Diamond; Lloyd F. Craver
Excerpt INTRODUCTION A review has been completed of the experience with lymphosarcoma at the Memorial Center for Cancer and Allied Diseases during the last 30 years. This has been a comprehensive s...
The New England Journal of Medicine | 1959
Daniel G. Miller; Henry D. Diamond; Lloyd F. Craver
CHLORAMBUCIL (P-[di-2-chloroethylamino]-phenylbutyric acid, or CB 1348) is an analogue of nitrogen mustard that may be administered orally. There have been several reports attesting to its usefulne...
Annals of Internal Medicine | 1958
Harrison F. Wood; Henry D. Diamond; Lloyd F. Craver; Elmer Pader; Samuel K. Elster
Excerpt Since the first description of C-reactive protein by Tillett and Francis in 1930, the occurrence of this substance, which is not present in the blood of normal individuals, has been noted b...
The American Journal of Medicine | 1959
Ruven Levitan; Henry D. Diamond; Lloyd F. Craver
Abstract Two cases of Hodgkins disease with esophageal varices are reported. Both patients had extensive liver involvement with Hodgkins disease, and the second patient had, in addition, constrictive pericarditis. To the best of our knowledge, no cases of esophageal varices in patients with Hodgkins disease involving the liver have been reported. The occurrence of varices in cancers of the liver and other pathological conditions is discussed.
The American Journal of Medicine | 1962
John Richmond; Robert S. Sherman; Henry D. Diamond; Lloyd F. Craver
Blood | 1953
Joseph H. Burchenal; M. L. Murphy; Rose Ruth Ellison; Marguerite P. Sykes; T. C. Tan; L. A. Leone; David A. Karnofsky; Lloyd F. Craver; H. W. Dargeon; C. P. Rhoads
The New England Journal of Medicine | 1958
Saul A. Rosenberg; Henry D. Diamond; Harold W. Dargeon; Lloyd F. Craver
Cancer | 1951
Chester M. Southam; Lloyd F. Craver; Harold W. Dargeon; Joseph H. Burchenal